Richard A Gonzalez Form 4 AbbVie / RICHARD A GONZALEZ ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GONZALEZ RICHARD A

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chairman of the Board and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.01 par value	08/07/2017		M		193,131	A	$51.42	469,623	D
Common stock, $0.01 par value	08/07/2017		S		6,779	D	$71.005	462,844	D
Common stock, $0.01 par value	08/07/2017		S		1,809	D	$71.025	461,035	D
Common stock, $0.01 par value	08/07/2017		S		100	D	$71.055	460,935	D
Common stock, $0.01 par value	08/07/2017		S		3	D	$71.065	460,932	D
Common stock, $0.01 par value	08/07/2017		S		6,200	D	$71.05	454,732	D
Common stock, $0.01 par value	08/07/2017		S		1,153	D	$71.015	453,579	D
Common stock, $0.01 par value	08/07/2017		S		1,800	D	$71.06	451,779	D
Common stock, $0.01 par value	08/07/2017		S		157,163	D	$71	294,616	D
Common stock, $0.01 par value	08/07/2017		S		1,100	D	$71.045	293,516	D
Common stock, $0.01 par value	08/07/2017		S		2,602	D	$71.04	290,914	D
Common stock, $0.01 par value	08/07/2017		S		3,158	D	$71.02	287,756	D
Common stock, $0.01 par value	08/07/2017		S		446	D	$71.035	287,310	D
Common stock, $0.01 par value	08/07/2017		S		9,618	D	$71.01	277,692	D
Common stock, $0.01 par value	08/07/2017		S		1,200	D	$71.03	276,492	D
Common stock, $0.01 par value								4,600(1)	I	By spouse
Common stock, $0.01 par value								450(1)	I	By step-daughter
Common stock, $0.01 par value								450(1)	I	By step-son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(2)	$51.42	08/07/2017		M			193,131	02/20/2017	02/19/2024	Common stock	193,131	$0	0	D

Explanation of Responses:

1. The reporting person disclaims beneficial ownership of these securities.

2. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

	Steven L. Scrogham, attorney-in-fact for Richard A. Gonzalez	08/08/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.